[Monoamine oxidase inhibitor in the treatment of attention deficit disorder of residual type. Apropos of a case].
Attention deficit disorder is common in children and it may continue during adolescence and adulthood. Some psychotropic drugs can improve the social, school and professional adaptation. A 16 year old girl suffering from an attention deficit disorder of the residual type according to the DSM III criteria was treated by toloxatone, a new monoamine oxidase inhibitor. According to clinical improvement observed with this drug, it may be considered as a new symptomatic treatment of this disorder.